Altimmune, Inc. (ALT)
NASDAQ: ALT · Real-Time Price · USD
5.24
-0.07 (-1.32%)
At close: Dec 5, 2025, 4:00 PM EST
5.28
+0.04 (0.76%)
After-hours: Dec 5, 2025, 7:59 PM EST
Altimmune Employees
Altimmune had 59 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
59
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$339
Profits / Employee
-$1,422,288
Market Cap
546.75M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ALT News
- 4 days ago - Altimmune Announces CEO Transition and Succession Plan - GlobeNewsWire
- 9 days ago - Altimmune to Participate in the Piper Sandler 37th Annual Healthcare Conference - GlobeNewsWire
- 15 days ago - Altimmune, Inc. (ALT) Presents at Jefferies London Healthcare Conference 2025 Transcript - Seeking Alpha
- 22 days ago - Altimmune: Probing Pemvi's MASH Data - Seeking Alpha
- 24 days ago - Altimmune Announces Publication of IMPACT Phase 2b Trial Data in The Lancet and Concurrent Late-Breaking Oral Presentation at AASLD The Liver Meeting® 2025 - GlobeNewsWire
- 4 weeks ago - Altimmune Presents AI-Based Analysis of Liver Fibrosis Reduction from IMPACT Phase 2b Trial of Pemvidutide in MASH in Late-breaking Poster at AASLD The Liver Meeting® 2025 - GlobeNewsWire
- 4 weeks ago - Altimmune, Inc. (ALT) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Altimmune Announces Third Quarter 2025 Financial Results and Business Updates - GlobeNewsWire